Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical phenotypes in α<sub>1</sub>-antitrypsin deficiency: a cluster analysis on EARCO data.

ERJ open research·2026
Same author

Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update.

Archivos de bronconeumologia·2026
Same author

[2027: A new year for a new epidemiological study of chronic obstructive pulmonary disease in Spain].

Open respiratory archives·2026
Same author

Real-world Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection Not Associated with Cystic Fibrosis: A Comparative Analysis From the INBREATHING Registry.

Archivos de bronconeumologia·2026
Same author

The EXACERBANTES Study (<i>Exacerbation of Chronic Obstructive Pulmonary Disease According to the ANTES Proposal</i>): Rationale, Goals and Design.

Open respiratory archives·2026
Same author

The World's Burden of Chronic Respiratory Disease: An Epidemiological Review of Asthma, COPD, Interstitial Lung Disease, and Smoking in the 21st Century.

Archivos de bronconeumologia·2026

Related Experiment Video

Updated: May 11, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Symptom variability in COPD: a narrative review.

Jose Luis Lopez-Campos1, Carmen Calero, Esther Quintana-Gallego

  • 1Unidad Medico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio, Seville, Spain. lcampos@separ.es

International Journal of Chronic Obstructive Pulmonary Disease
|May 21, 2013
PubMed
Summary

Chronic obstructive pulmonary disease (COPD) symptoms fluctuate daily, peaking in the early morning and at night. Understanding these variations may guide new long-term COPD treatment strategies.

Keywords:
aclidiniumformoterolglycopyrroniumindacaterolrapid-onset bronchodilatorssymptom perception

More Related Videos

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

Related Experiment Videos

Last Updated: May 11, 2026

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians
04:03

Alternative Therapy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Moving Cupping Along Meridians

Published on: September 27, 2024

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

Area of Science:

  • Pulmonary Medicine
  • Respiratory Research

Background:

  • Traditionally, Chronic Obstructive Pulmonary Disease (COPD) is viewed as a progressive illness with steadily worsening symptoms.
  • Recent evidence challenges this, revealing significant daily and weekly variations in COPD symptom perception.
  • These fluctuations impact patients' daily activities and quality of life.

Purpose of the Study:

  • To investigate the diurnal variation in COPD symptom perception.
  • To explore the potential impact of rapid-onset bronchodilators on morning COPD symptoms.
  • To propose symptom variation as a new target for long-term COPD management.

Main Methods:

  • Review of recent studies on COPD symptom perception.
  • Analysis of data on symptom variation over 24-hour periods.
  • Consideration of clinical trial data on rapid-onset long-acting bronchodilators.

Main Results:

  • COPD symptoms exhibit significant variation, with peaks occurring in the early morning and at night.
  • Rapid-onset long-acting bronchodilators may offer a new therapeutic approach for managing morning symptoms.
  • Current long-acting bronchodilators like formoterol and indacaterol have a rapid onset of action.

Conclusions:

  • COPD symptom perception is not constant and shows predictable diurnal patterns.
  • Addressing these symptom variations, particularly morning peaks, could be a novel target in COPD treatment.
  • Healthcare providers should incorporate assessment of symptom fluctuation into patient management plans.